Hjärta & Kärl, Hemostas- och Fibrinolys, Hypertension 96-00


Devereux RB, Roman MJ, Palmieri V, Okin PM, Boman K, Gerdts E, et al. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. J Hypertens 2000;18(8):1129-38.

Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 2000;31(1):26-32.

Ohgren B, Weinehall L, Stegmayr B, Boman K, Hallmans G, Wall S. What else adds to hypertension in predicting stroke? An incident case- referent study. J Intern Med 2000;248(6):475-82.

Ohgren B, Weinehall L, Jansson J-H, Stegmayr B, Boman K, Hallmans G, Wall S. Alcohol Consumption Pattern as predictor for Acute Myocardial Infarction. An incident Case-Referent study. JIM 2000; 248: 475-482.

Lindholm L, Hallgren CG, Boman K, Markgren K, Weinehall L, Ogren JE. Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease? Health Policy 1999;48(3):155-70.

Lindholm L, Hallgren CG, Boman K, Markgren K, Weinehall L, Ogren JE. [Cost-effectiveness analysis of cardiovascular disease prevention: a graded list as aid to the rational distribution of resources]. Lakartidningen 1999;96(23):2858-63, 2865-6.

Lindahl. B., B. Dinesen, M. Eliasson, M. Roder, J.H. Jansson, F. Huhtasaari, G. Hallmans. High proinsulin concentration preceeds acute myocardial infarction in a non-diabetic population. Metabolism, 1999. 48: p. 1197-1202.

Lindahl. B., T.K. Nilsson, J.H. Jansson, K. Asplund, G. Hallmans. Improved fibrinolysis by intensive lifestyle intervension. A randomized trial in subjects with impaired glucose tolerance. Journal of Internal Medicine, 1999. 246: p. 105-12.

Soderberg. S., B. Ahren, J.H. Jansson, O. Johnson, G. Hallmans, K. Asplund, T. Olsson. Leptin is associated with increased risk of myocardial infarction. Journal of Internal Medicine, 1999. 246(4): p. 409-18.

Weinehall L, Westman G, Hellsten G, Boman K, Hallmans G, Pearson TA, Wall 8. Shifting the distribution of risk: Results of a community intervention in a Swedish programme for the prevention of Cardiovascular disease. Journal of Epidemiology and Community Health 1999; 53(4):243-50.

Nadal. M, Boman K. Impaired Circadian Rhythm of Vasopressin in Chronic heart Failure and in healthy Subjects treated with oral Furosemide. Submitted Journal of Internal Medicine.

DAAF Trial Hornestam B, et al; N-terminal proANF in acute atriial fibrillation: a biochemical marker of atrial pressures but not a predictor for conversion to sinus rhythm. Digitalis in Acut Atrial Fibrillation group (Boman K. Local kordinator). Am Heart J. 1998; 135: 1040-7.

Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998;98(21):2241-7.

Weinehall L, Johnson O, Jansson JH, Boman K, Huhtasaari F, Hallmans G, et al. Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from northern Sweden. J Intern Med 1998;243(2):99-107.

Jansson J-H, Boman K, Brännström M, Nilsson T K. High concentration of thrombomodulin in plasma prediets haemorrhage in patients on long-term anticoagulant treatment. Circulation. 1997; 96;2938-2943. This arcticle was followed by an Editorial.

Nilsson J B, Näslund U, Jansson J-H, Boman K, Nilsson T K. Effects of Streptokinase on plasma concentrations of factors in the fibrinolytic systern in acute myocardial infarction. Fibrinolysis&Proteolysis 1997; 11(4) 103-109.

The DAAF Trial group. Digitalis in Acute Atrial Fibrillation. Results of the DAAF Trial. Eur Heart J 1997; 18:649-54.( Boman K Local koordinator). Cholesterol Lowering and the use of Healtheare Resources. Results of the Scandinavian Survival Study. Circulation 1996,93: 1796-1802.

Cost-effectiveness of cholesterol lowering. Results of the Scandinavian Survival Study. Eur Heart J, Vol. 1996,17: 1001-1007.

Jansson J-H, Brännström M, Boman K, Nilsson T K. Inereased levels of plasma thrombomodulin are associated with vascular and all-cause morwity in patients on tong- term antieoagulant treatment. Eur Heart J 1996; 17: 1503-1505.

Nilsson T K, Thorgersen A M, Jansson J-H, Boman K. Comparison of von Willebrand faktor and tissue plasminogen activator concentrations in plasma and serum. Clinical Chemistry 1996,42.976-7.

Stöd vår forskning redan idag

Så hjälper du till

Stiftelsen vill inspirera och stödja yngre men även äldre läkare, sjuksköterskor, apotekare med flera till att forska inom områdena medicin och omvårdnad inom Skellefteå sjukvård (kommunerna Skellefteå och Norsjö).

Postgiro & Bankgiro

Stöd vår verksamhet genom att sätta in pengar på följande Post- och Bankgiro:

Stiftelsens postgiro 444 81 29-9
Stiftelsens bankgiro 710-9721
Stiftelsens swish 1233351574

Dela vår hemsida

Hjälp vår stiftelse och våra forskare genom att sprida vår sida vidare via sociala medier.
Information om cookies